Lynch Regenerative Medicine
PrivateLast Round
Early Stage
VC
Jul 15, 2026
Total Funding Raised
$7.45M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lynch Regenerative Medicine is a biotherapeutics company that develops and commercializes advanced skin rejuvenation and regeneration solutions using patented platelet-derived growth factor (PDGF) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lynch Regenerative Medicine Comparables
Compare Lynch Regenerative Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolarityBio, Inc. | 81% | |
| Merakris Therapeutics | 77% | |
| Theradaptive | 76% |
Lynch Regenerative Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jul 15, 2026 | ||||
| Series A | Jul 16, 2024 | ||||
| Seed | Feb 1, 2024 | ||||
| Accelerator | Sep 1, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
$15M raised in early stage VC funding.
- Jun 11, 2026
Grew 19% QoQ, from 27 to 32 employees.
Recent news
Latest coverage and updates
- receives_financingAug 13, 2026
Lynch Regenerative Medicine, LLC. receives financing of $15M in venture funding.
Lynch Regenerative Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lynch Regenerative Medicine's valuation, stock price, and market status.
Is Lynch Regenerative Medicine a public or private company?
Lynch Regenerative Medicine is a private company.
What is the current stock price of Lynch Regenerative Medicine?
Lynch Regenerative Medicine is a private company with no public stock price. No recent secondary market data is available.
How much is Lynch Regenerative Medicine worth (valuation)?
Valuation information for Lynch Regenerative Medicine is not publicly available.
Can I buy Lynch Regenerative Medicine stock?
Lynch Regenerative Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lynch Regenerative Medicine's last funding round?
Lynch Regenerative Medicine's most recent funding round was Series A on July 17, 2024.
Who are the main investors in Lynch Regenerative Medicine?
Investor information for Lynch Regenerative Medicine is not publicly disclosed.
Will Lynch Regenerative Medicine IPO soon?
No public IPO plans have been announced for Lynch Regenerative Medicine.
How can I track Lynch Regenerative Medicine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lynch Regenerative Medicine's secondary market activity and sign up for updates.